Previous 10 | Next 10 |
JUPITER, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deploy...
Dyadic International (NASDAQ:DYAI) and Phibro Animal Health (NASDAQ:PAHC) signed an exclusive license agreement to develop and commercialize animal health vaccine. Under the agreement, Dyadic granted Phibro an exclusive license for its proprietary C1 -cell protein production platform to produ...
JUPITER, Fla., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying, and deploy...
JUPITER, Fla., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to acce...
JUPITER, Fla., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deployi...
JUPITER, Fla., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deployi...
Two sample Breakout Stocks for Week 51 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. This past week, 1 stock beat 10% peak gains in BYFC +28.2% despite high negative Momentum Gauge® values from November continui...
Gainers: SK Telecom (NYSE:SKM) +73%. Genfit (NASDAQ:GNFT) +44%. Bellerophon Therapeutics (NASDAQ:BLPH) +27%. Spruce Biosciences (NASDAQ:SPRB) +25%. AMC Entertainment Holdings (NYSE:AMC) +21%. Stran & Company (NASDAQ:STRNW) +22%. AeroCentury (NYSE:ACY) +19%. cbdMD (NYSE:YCBD) +19%. Net 1 U...
Genfit (NASDAQ:GNFT) +39% inks licensing deal for elafibranor with Ipsen. Spruce Biosciences (NASDAQ:SPRB) +21%. Cerner (NASDAQ:CERN) +17% gains on report Oracle in talks to acquire for about $30B. Bottomline Technologies (NASDAQ:EPAY) +15% agrees to be taken pri...
Dyadic International (NASDAQ:DYAI) perks up 5.8% premarket after entering into a Research, License and Collaboration Agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE:JNJ). Under the terms of the Agreement, Janssen w...
News, Short Squeeze, Breakout and More Instantly...
Dyadic International Inc. Company Name:
DYAI Stock Symbol:
OTCMKTS Market:
Dyadic International Inc. Website:
JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for ...
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well a...
Human Health Sector Final Clinical Study Report has been issued for the First-In-Human Phase 1 clinical trial demonstrating safety and antibody response for DYAI-100, a recombinant protein receptor binding domain booster vaccine candidate for protection against C...